About us
Contact Us
Schedule a Sleep Test
Introduction of CPAP Pro
CPAP PRO Limited has been dedicated to providing comprehensive diagnostic and therapeutic solutions for patients with sleep apnea since its establishment in 2019. Our services cover standard polysomnography (PSG), home sleep apnea testing (HSAT), and rapid sleep screening using AI-powered sleep testing devices, ensuring full-process coverage from initial screening to precise diagnosis. In terms of treatment equipment, we offer various types of ventilators, including fixed-pressure CPAP machines, auto-adjusting APAP machines, and bi-level BiPAP machines, along with professional accessories to meet the personalized needs of different patients.
Our products and services have been recognized and adopted by numerous leading local medical institutions, with partnerships spanning both public and private hospitals.
With over seven years of local experience and clinical validation, we continuously introduce high-quality products and advanced technologies from Europe, America, and Asia, while providing comprehensive pre-sales consultations and post-sales support. We place great emphasis on customer experience and offer independent testing rooms where you can personally experience product performance under the guidance of professionals, helping you regain quality sleep and embrace a healthy lifestyle.
Partner Introduction
Our company is currently an authorized distributor for Chengdu Yunweikang Medical Technology Co., Ltd. Yunweikang, inheriting the technical expertise of GE Healthcare’s team, specializes in the research and development of reflective vital sign monitoring technology and related medical products. It is committed to providing hospitals and users with accurate, efficient, convenient, comfortable, and cost-effective sleep screening products and solutions. Its vision is to become a global leader in the field of sleep screening, particularly in children’s sleep screening.
2024
- Clinical clients exceed 1,000, with SCI papers having an Impact Factor of 60+
- Start the R&D for the AI 3.0 sleep screening devices
- Initiative of a 200,000-person sleep screening program
- A successful launch of the cerebral oximetry
- Collaborations with renowned domestic universities and hospitals to jointly develop brain science-related devices and applications
2020
- Major breakthrough in AI algorithms and systems, successfully overcoming the issue of "low accuracy in screening mild to moderate OSA with Level 4 sleep monitoring devices and completing clinical validation
2023
- Launch of the AI 2.0 sleep screening device, with annual screenings surpassing 100,000 people
- The newly developed cerebral oximetry obtained medical device registration certificates
2021
- Secured the second-highest national sales share at 18.48% (second only to Philips Respironics), providing screening services to over 50,000 patients (nearly half of them children)
2019
- Launch of the 3rd generation device, adopted by over 200 hospitals
2018
- Development and promotion of 2nd and 3rd generation device, with supporting academic research published
2017
- Clinical trial research conducted in over 50 renowned tertiary hospitals nationwide
2016
The 1st generation device (the world's first of its kind) obtained medical certification
2015
Pioneered the development of reflective vital sign monitoring technology globally
2014
- Company establishment, with a team formed to conduct foundational research
About Us
Contact Us
Schedule a Sleep Test
Introduction of CPAP Pro
CPAP PRO Limited has been dedicated to providing comprehensive diagnostic and therapeutic solutions for patients with sleep apnea since its establishment in 2019. Our services cover standard polysomnography (PSG), home sleep apnea testing (HSAT), and rapid sleep screening using AI-powered sleep testing devices, ensuring full-process coverage from initial screening to precise diagnosis. In terms of treatment equipment, we offer various types of ventilators, including fixed-pressure CPAP machines, auto-adjusting APAP machines, and bi-level BiPAP machines, along with professional accessories to meet the personalized needs of different patients.
Our products and services have been recognized and adopted by numerous leading local medical institutions, with partnerships spanning both public and private hospitals.
With over seven years of local experience and clinical validation, we continuously introduce high-quality products and advanced technologies from Europe, America, and Asia, while providing comprehensive pre-sales consultations and post-sales support. We place great emphasis on customer experience and offer independent testing rooms where you can personally experience product performance under the guidance of professionals, helping you regain quality sleep and embrace a healthy lifestyle.
Partner Introduction
Our company is currently an authorized distributor for Chengdu Yunweikang Medical Technology Co., Ltd. Yunweikang, inheriting the technical expertise of GE Healthcare’s team, specializes in the research and development of reflective vital sign monitoring technology and related medical products. It is committed to providing hospitals and users with accurate, efficient, convenient, comfortable, and cost-effective sleep screening products and solutions. Its vision is to become a global leader in the field of sleep screening, particularly in children’s sleep screening.
2024
- Clinical clients exceed 1,000, with SCI papers having an Impact Factor of 60+
- Start the R&D for the AI 3.0 sleep screening devices
- Initiative of a 200,000-person sleep screening program
- A successful launch of the cerebral oximetry
- Collaborations with renowned domestic universities and hospitals to jointly develop brain science-related devices and applications
2023
- Launch of the AI 2.0 sleep screening device, with annual screenings surpassing 100,000 people
- The newly developed cerebral oximetry obtained medical device registration certificates
2021
- Secured the second-highest national sales share at 18.48% (second only to Philips Respironics), providing screening services to over 50,000 patients (nearly half of them children)
2020
- Major breakthrough in AI algorithms and systems, successfully overcoming the issue of "low accuracy in screening mild to moderate OSA with Level 4 sleep monitoring devices and completing clinical validation
2019
- Launch of the 3rd generation device, adopted by over 200 hospitals
2018
- Development and promotion of 2nd and 3rd generation device, with supporting academic research published
2017
- Clinical trial research conducted in over 50 renowned tertiary hospitals nationwide
2016
- The 1st generation device (the world's first of its kind) obtained medical certification
2015
- Pioneered the development of reflective vital sign monitoring technology globally
2014
- Company establishment, with a team formed to conduct foundational research
About Us
Contact Us
Schedule a Sleep Test
Introduction of CPAP Pro
CPAP PRO Limited has been dedicated to providing comprehensive diagnostic and therapeutic solutions for patients with sleep apnea since its establishment in 2019. Our services cover standard polysomnography (PSG), home sleep apnea testing (HSAT), and rapid sleep screening using AI-powered sleep testing devices, ensuring full-process coverage from initial screening to precise diagnosis. In terms of treatment equipment, we offer various types of ventilators, including fixed-pressure CPAP machines, auto-adjusting APAP machines, and bi-level BiPAP machines, along with professional accessories to meet the personalized needs of different patients.
Our products and services have been recognized and adopted by numerous leading local medical institutions, with partnerships spanning both public and private hospitals.
With over seven years of local experience and clinical validation, we continuously introduce high-quality products and advanced technologies from Europe, America, and Asia, while providing comprehensive pre-sales consultations and post-sales support. We place great emphasis on customer experience and offer independent testing rooms where you can personally experience product performance under the guidance of professionals, helping you regain quality sleep and embrace a healthy lifestyle.
Partner Introduction
Our company is currently an authorized distributor for Chengdu Yunweikang Medical Technology Co., Ltd. Yunweikang, inheriting the technical expertise of GE Healthcare’s team, specializes in the research and development of reflective vital sign monitoring technology and related medical products. It is committed to providing hospitals and users with accurate, efficient, convenient, comfortable, and cost-effective sleep screening products and solutions. Its vision is to become a global leader in the field of sleep screening, particularly in children’s sleep screening.
Milestones of Yunweikang Medical
2024
- Clinical clients exceed 1,000, with SCI papers having an Impact Factor of 60+
- Start the R&D for the AI 3.0 sleep screening devices
- Initiative of a 200,000-person sleep screening program
- A successful launch of the cerebral oximetry
- Collaborations with renowned domestic universities and hospitals to jointly develop brain science-related devices and applications
2023
- Launch of the AI 2.0 sleep screening device, with annual screenings surpassing 100,000 people
- The newly developed cerebral oximetry obtained medical device registration certificates
2021
- Secured the second-highest national sales share at 18.48% (second only to Philips Respironics), providing screening services to over 50,000 patients (nearly half of them children)
2020
- Major breakthrough in AI algorithms and systems, successfully overcoming the issue of "low accuracy in screening mild to moderate OSA with Level 4 sleep monitoring devices and completing clinical validation
2019
- Launch of the 3rd generation device, adopted by over 200 hospitals
2018
- Development and promotion of 2nd and 3rd generation device, with supporting academic research published
2017
- Clinical trial research conducted in over 50 renowned tertiary hospitals nationwide
2016
- The 1st generation device (the world's first of its kind) obtained medical certification
2015
- Pioneered the development of reflective vital sign monitoring technology globally
2014
- Company establishment, with a team formed to conduct foundational research